Source | Evidence on protein | Close homologs |
---|---|---|
Cuervo et al. | no | yes: 0 |
Hassani et al. | no | yes: 0 |
Forrest at al. (metacyclic) | no | yes: 0 |
Forrest at al. (procyclic) | no | yes: 0 |
Silverman et al. | no | yes: 0 |
Pissara et al. | yes | yes: 20 |
Source | Evidence on protein | Close homologs |
---|---|---|
Pires et al. | no | yes: 0 |
Source | Evidence on protein | Close homologs |
---|---|---|
Silverman et al. | no | yes: 0 |
Source | Evidence on protein | Close homologs |
---|---|---|
Jamdhade et al. | no | yes: 0 |
Source | Evidence on protein | Close homologs |
---|---|---|
DeepLoc | ||
SignalP6 | yes | yes: 11, no: 9 |
NetGPI | no | yes: 0, no: 20 |
Term | Name | Level | Count |
---|---|---|---|
GO:0016020 | membrane | 2 | 3 |
GO:0110165 | cellular anatomical entity | 1 | 3 |
Related structures:
AlphaFold database: A0A3Q8IG97
Term | Name | Level | Count |
---|---|---|---|
GO:0006629 | lipid metabolic process | 3 | 21 |
GO:0008152 | metabolic process | 1 | 21 |
GO:0044238 | primary metabolic process | 2 | 21 |
GO:0071704 | organic substance metabolic process | 2 | 21 |
Term | Name | Level | Count |
---|---|---|---|
GO:0003824 | catalytic activity | 1 | 12 |
GO:0004806 | triglyceride lipase activity | 5 | 12 |
GO:0016298 | lipase activity | 4 | 12 |
GO:0016787 | hydrolase activity | 2 | 12 |
GO:0016788 | hydrolase activity, acting on ester bonds | 3 | 12 |
GO:0052689 | carboxylic ester hydrolase activity | 4 | 12 |
Leishmania | From | To | Domain/Motif | Score |
---|---|---|---|---|
CLV_C14_Caspase3-7 | 267 | 271 | PF00656 | 0.383 |
CLV_C14_Caspase3-7 | 32 | 36 | PF00656 | 0.436 |
CLV_NRD_NRD_1 | 111 | 113 | PF00675 | 0.280 |
CLV_NRD_NRD_1 | 143 | 145 | PF00675 | 0.496 |
CLV_NRD_NRD_1 | 37 | 39 | PF00675 | 0.390 |
CLV_PCSK_KEX2_1 | 111 | 113 | PF00082 | 0.488 |
CLV_PCSK_KEX2_1 | 143 | 145 | PF00082 | 0.569 |
CLV_PCSK_KEX2_1 | 37 | 39 | PF00082 | 0.369 |
CLV_PCSK_SKI1_1 | 152 | 156 | PF00082 | 0.370 |
CLV_PCSK_SKI1_1 | 187 | 191 | PF00082 | 0.514 |
DOC_PP4_FxxP_1 | 201 | 204 | PF00568 | 0.417 |
DOC_USP7_MATH_1 | 194 | 198 | PF00917 | 0.555 |
DOC_USP7_MATH_1 | 2 | 6 | PF00917 | 0.660 |
DOC_USP7_MATH_1 | 36 | 40 | PF00917 | 0.489 |
DOC_USP7_MATH_1 | 52 | 56 | PF00917 | 0.591 |
DOC_USP7_MATH_1 | 64 | 68 | PF00917 | 0.406 |
LIG_14-3-3_CanoR_1 | 100 | 110 | PF00244 | 0.445 |
LIG_14-3-3_CanoR_1 | 143 | 147 | PF00244 | 0.356 |
LIG_14-3-3_CanoR_1 | 193 | 199 | PF00244 | 0.318 |
LIG_14-3-3_CanoR_1 | 226 | 234 | PF00244 | 0.416 |
LIG_14-3-3_CanoR_1 | 37 | 41 | PF00244 | 0.566 |
LIG_BRCT_BRCA1_1 | 241 | 245 | PF00533 | 0.664 |
LIG_EH1_1 | 67 | 75 | PF00400 | 0.391 |
LIG_FHA_1 | 273 | 279 | PF00498 | 0.541 |
LIG_FHA_1 | 69 | 75 | PF00498 | 0.446 |
LIG_FHA_2 | 102 | 108 | PF00498 | 0.494 |
LIG_FHA_2 | 44 | 50 | PF00498 | 0.510 |
LIG_HP1_1 | 194 | 198 | PF01393 | 0.318 |
LIG_LIR_Apic_2 | 200 | 204 | PF02991 | 0.430 |
LIG_LIR_Gen_1 | 138 | 146 | PF02991 | 0.409 |
LIG_LIR_Gen_1 | 242 | 253 | PF02991 | 0.586 |
LIG_LIR_Gen_1 | 39 | 50 | PF02991 | 0.367 |
LIG_LIR_Nem_3 | 138 | 142 | PF02991 | 0.433 |
LIG_LIR_Nem_3 | 242 | 248 | PF02991 | 0.554 |
LIG_LIR_Nem_3 | 287 | 292 | PF02991 | 0.445 |
LIG_LIR_Nem_3 | 39 | 45 | PF02991 | 0.446 |
LIG_LIR_Nem_3 | 46 | 50 | PF02991 | 0.433 |
LIG_PDZ_Class_2 | 303 | 308 | PF00595 | 0.778 |
LIG_PTB_Apo_2 | 205 | 212 | PF02174 | 0.425 |
LIG_PTB_Apo_2 | 41 | 48 | PF02174 | 0.354 |
LIG_PTB_Apo_2 | 62 | 69 | PF02174 | 0.508 |
LIG_PTB_Phospho_1 | 41 | 47 | PF10480 | 0.353 |
LIG_REV1ctd_RIR_1 | 187 | 193 | PF16727 | 0.318 |
LIG_SH2_CRK | 160 | 164 | PF00017 | 0.350 |
LIG_SH2_CRK | 42 | 46 | PF00017 | 0.486 |
LIG_SH2_GRB2like | 42 | 45 | PF00017 | 0.348 |
LIG_SH2_NCK_1 | 42 | 46 | PF00017 | 0.515 |
LIG_SH2_NCK_1 | 47 | 51 | PF00017 | 0.559 |
LIG_SH2_PTP2 | 85 | 88 | PF00017 | 0.338 |
LIG_SH2_SRC | 42 | 45 | PF00017 | 0.560 |
LIG_SH2_SRC | 47 | 50 | PF00017 | 0.617 |
LIG_SH2_STAT5 | 139 | 142 | PF00017 | 0.454 |
LIG_SH2_STAT5 | 199 | 202 | PF00017 | 0.427 |
LIG_SH2_STAT5 | 253 | 256 | PF00017 | 0.544 |
LIG_SH2_STAT5 | 291 | 294 | PF00017 | 0.500 |
LIG_SH2_STAT5 | 85 | 88 | PF00017 | 0.473 |
LIG_SH3_3 | 110 | 116 | PF00018 | 0.473 |
LIG_SH3_3 | 188 | 194 | PF00018 | 0.535 |
LIG_SH3_3 | 232 | 238 | PF00018 | 0.403 |
LIG_SUMO_SIM_anti_2 | 7 | 13 | PF11976 | 0.564 |
LIG_SUMO_SIM_par_1 | 194 | 200 | PF11976 | 0.516 |
LIG_TRAF2_1 | 104 | 107 | PF00917 | 0.318 |
LIG_TYR_ITIM | 40 | 45 | PF00017 | 0.456 |
LIG_TYR_ITIM | 83 | 88 | PF00017 | 0.446 |
LIG_WRC_WIRS_1 | 198 | 203 | PF05994 | 0.446 |
MOD_CK1_1 | 197 | 203 | PF00069 | 0.567 |
MOD_CK1_1 | 220 | 226 | PF00069 | 0.483 |
MOD_CK1_1 | 239 | 245 | PF00069 | 0.699 |
MOD_CK1_1 | 4 | 10 | PF00069 | 0.723 |
MOD_CK2_1 | 101 | 107 | PF00069 | 0.449 |
MOD_GlcNHglycan | 101 | 104 | PF01048 | 0.462 |
MOD_GlcNHglycan | 122 | 125 | PF01048 | 0.331 |
MOD_GlcNHglycan | 20 | 23 | PF01048 | 0.675 |
MOD_GlcNHglycan | 239 | 242 | PF01048 | 0.651 |
MOD_GlcNHglycan | 266 | 270 | PF01048 | 0.573 |
MOD_GlcNHglycan | 296 | 299 | PF01048 | 0.580 |
MOD_GlcNHglycan | 89 | 94 | PF01048 | 0.572 |
MOD_GSK3_1 | 25 | 32 | PF00069 | 0.529 |
MOD_GSK3_1 | 64 | 71 | PF00069 | 0.534 |
MOD_LATS_1 | 224 | 230 | PF00433 | 0.318 |
MOD_N-GLC_1 | 43 | 48 | PF02516 | 0.454 |
MOD_NEK2_1 | 135 | 140 | PF00069 | 0.429 |
MOD_NEK2_1 | 18 | 23 | PF00069 | 0.599 |
MOD_NEK2_1 | 189 | 194 | PF00069 | 0.523 |
MOD_NEK2_1 | 225 | 230 | PF00069 | 0.511 |
MOD_NEK2_1 | 68 | 73 | PF00069 | 0.509 |
MOD_NEK2_1 | 99 | 104 | PF00069 | 0.433 |
MOD_NEK2_2 | 194 | 199 | PF00069 | 0.318 |
MOD_PIKK_1 | 101 | 107 | PF00454 | 0.558 |
MOD_PIKK_1 | 29 | 35 | PF00454 | 0.426 |
MOD_PK_1 | 69 | 75 | PF00069 | 0.396 |
MOD_PKA_2 | 142 | 148 | PF00069 | 0.349 |
MOD_PKA_2 | 220 | 226 | PF00069 | 0.437 |
MOD_PKA_2 | 294 | 300 | PF00069 | 0.604 |
MOD_PKA_2 | 36 | 42 | PF00069 | 0.573 |
MOD_PKA_2 | 99 | 105 | PF00069 | 0.414 |
MOD_Plk_1 | 152 | 158 | PF00069 | 0.473 |
MOD_Plk_1 | 43 | 49 | PF00069 | 0.441 |
MOD_Plk_4 | 194 | 200 | PF00069 | 0.506 |
MOD_Plk_4 | 69 | 75 | PF00069 | 0.425 |
MOD_Plk_4 | 78 | 84 | PF00069 | 0.636 |
TRG_ENDOCYTIC_2 | 139 | 142 | PF00928 | 0.445 |
TRG_ENDOCYTIC_2 | 160 | 163 | PF00928 | 0.533 |
TRG_ENDOCYTIC_2 | 42 | 45 | PF00928 | 0.442 |
TRG_ENDOCYTIC_2 | 47 | 50 | PF00928 | 0.479 |
TRG_ENDOCYTIC_2 | 85 | 88 | PF00928 | 0.472 |
TRG_ER_diArg_1 | 110 | 112 | PF00400 | 0.280 |
TRG_ER_diArg_1 | 142 | 144 | PF00400 | 0.569 |
Protein | Taxonomy | Sequence identity | Coverage |
---|---|---|---|
A0A0N1I0D0 | Leptomonas seymouri | 30% | 86% |
A0A0S4IJE8 | Bodo saltans | 32% | 94% |
A0A0S4J5D7 | Bodo saltans | 35% | 99% |
A0A0S4JTA1 | Bodo saltans | 34% | 100% |
A0A1X0NH29 | Trypanosomatidae | 35% | 100% |
A0A1X0NZH3 | Trypanosomatidae | 32% | 73% |
A0A1X0P001 | Trypanosomatidae | 35% | 90% |
A0A3Q8IFI3 | Leishmania donovani | 32% | 100% |
A0A3S7X4C1 | Leishmania donovani | 37% | 100% |
A2QSY5 | Aspergillus niger (strain CBS 513.88 / FGSC A1513) | 27% | 100% |
A4HJN0 | Leishmania braziliensis | 32% | 100% |
A4HLK7 | Leishmania braziliensis | 40% | 100% |
A4I6H7 | Leishmania infantum | 100% | 100% |
A4I6H8 | Leishmania infantum | 38% | 100% |
A4I752 | Leishmania infantum | 32% | 100% |
B8NIB8 | Aspergillus flavus (strain ATCC 200026 / FGSC A1120 / IAM 13836 / NRRL 3357 / JCM 12722 / SRRC 167) | 25% | 100% |
C9ZME7 | Trypanosoma brucei gambiense (strain MHOM/CI/86/DAL972) | 31% | 84% |
E9B246 | Leishmania mexicana (strain MHOM/GT/2001/U1103) | 33% | 100% |
O42807 | Aspergillus niger | 27% | 100% |
O42815 | Aspergillus tubingensis | 26% | 100% |
O59952 | Thermomyces lanuginosus | 29% | 100% |
P0CT91 | Sodiomyces alcalophilus | 28% | 74% |
P19515 | Rhizomucor miehei | 31% | 85% |
P61869 | Penicillium cyclopium | 29% | 100% |
P61870 | Penicillium camembertii | 29% | 100% |
Q0CBM7 | Aspergillus terreus (strain NIH 2624 / FGSC A1156) | 28% | 100% |
Q2UNW5 | Aspergillus oryzae (strain ATCC 42149 / RIB 40) | 25% | 100% |
Q4Q615 | Leishmania major | 31% | 100% |
Q4Q6I0 | Leishmania major | 89% | 100% |
Q9BHD5 | Leishmania major | 36% | 100% |
Q9P979 | Aspergillus awamori | 27% | 100% |
Q9XTR8 | Caenorhabditis elegans | 29% | 87% |
V5B761 | Trypanosoma cruzi | 31% | 100% |